Tempus AI is a precision-medicine company applying AI to genomic, clinical, and multimodal health data to guide diagnostics and treatment decisions, particularly in oncology and cardiology. The company was founded in January 2015 by Eric Lefkofsky, who also co-founded Groupon, Echo Global Logistics, InnerWorkings, and Mediaocean earlier in his career.
Tempus AI trades publicly on the Nasdaq under the ticker TEM following its June 2024 initial public offering, with a market capitalization near $11.7 billion as of September 2026. The company's platform combines genomic sequencing with clinical and AI-driven analysis to help physicians select therapies tailored to individual patients.